The pharma industry is undergoing a seismic shift, not just in terms of groundbreaking drug discoveries but also in how it finds and fosters talent. As healthcare employees, understanding where pharma is sourcing innovative minds can provide insights into the evolving landscape of our profession. Here’s a closer look at where the pharma industry will find employees who can drive the next wave of innovation.

Social media is increasingly used by health-conscious patients. However, the highly regulated nature of the pharma industry poses unique challenges. Adhering to guidelines set by regulatory bodies like the FDA while effectively engaging with your audience requires a strategic approach. Here’s how pharma marketers can leverage social media to their advantage while staying compliant.

Direct-to-consumer (DTC) advertising has always been a crucial strategy for reaching patients and encouraging them to seek new treatments. However, as the healthcare landscape evolves, so must our approaches to DTC advertising. The complexity of today’s barriers requires innovative and adaptive strategies to ensure we effectively connect with consumers. Here’s why new approaches are essential.

Insurance plans like Medicare and commercial plans cover fewer medications and add more restrictions on coverage, making it harder for people to afford the medicines they need. Patients may have to pay more out of pocket before insurance starts covering their medical costs, and some drugs may not be covered at all. This can lead to financial strain and difficulty accessing necessary medications.

According to an FTC report, PBMs are central to the complex pharmaceutical distribution chain that delivers medicines from manufacturers to patients. PBMs serve as middlemen, negotiating the terms and conditions for prescription access. Those who work in the industry know this, but the critical question is, “What’s going to be done about it?”

Alzheimer’s will affect 11 million people in the United States by 2040. The amyloid hypothesis holds that sticky plaques and other so-called amyloid-beta proteins build up in the brain and prompt changes that cause Alzheimer’s disease’s cruel decline, gradually stealing a person’s mastery of everyday life, cherished memories, and, finally, their sense of self. But are we sure?

The number of TV ads for new prescription drugs is increasing, and the audience(s) aren’t paying any attention. It is more than a matter of mistrust; DTC marketers want to make a name for themselves by listening to agency people who are only interested in getting awards. There is too much turnover within DTC marketing, and new managers are clueless about the changes that have taken place in the current environment.